19.52
price up icon1.46%   0.28
after-market Handel nachbörslich: 19.52
loading
Schlusskurs vom Vortag:
$19.24
Offen:
$19.19
24-Stunden-Volumen:
182.67K
Relative Volume:
0.53
Marktkapitalisierung:
$791.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-136.98M
KGV:
-4.8557
EPS:
-4.02
Netto-Cashflow:
$-126.63M
1W Leistung:
+1.61%
1M Leistung:
+3.94%
6M Leistung:
-11.09%
1J Leistung:
-25.27%
1-Tages-Spanne:
Value
$18.39
$19.64
1-Wochen-Bereich:
Value
$18.39
$20.63
52-Wochen-Spanne:
Value
$15.47
$36.37

Arrivent Biopharma Inc Stock (AVBP) Company Profile

Name
Firmenname
Arrivent Biopharma Inc
Name
Telefon
240-780-6356
Name
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Name
Mitarbeiter
52
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AVBP's Discussions on Twitter

Vergleichen Sie AVBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AVBP
Arrivent Biopharma Inc
19.52 804.89M 0 -136.98M -126.63M -4.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Fortgesetzt Goldman Buy
2025-03-20 Eingeleitet B. Riley Securities Buy
2025-03-10 Eingeleitet Guggenheim Buy
2024-07-22 Eingeleitet Oppenheimer Outperform
2024-04-30 Eingeleitet H.C. Wainwright Buy
2024-02-20 Eingeleitet Citigroup Buy
2024-02-20 Eingeleitet Goldman Buy
2024-02-20 Eingeleitet Jefferies Buy
Alle ansehen

Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten

pulisher
12:05 PM

Institutional scanner results for ArriVent BioPharma Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser

12:05 PM
pulisher
Sep 04, 2025

Will ArriVent BioPharma Inc. benefit from macro trendsBond Market & AI Driven Price Forecasts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Real time breakdown of ArriVent BioPharma Inc. stock performanceWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is ArriVent BioPharma Inc. showing signs of accumulation2025 Year in Review & Reliable Entry Point Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-04 00:41:04 - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-04 08:31:42 - khodrobank.com

Sep 04, 2025
pulisher
Sep 03, 2025

Smart tools for monitoring ArriVent BioPharma Inc.’s price actionQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for ArriVent BioPharma Inc.Analyst Downgrade & Risk Managed Trade Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does ArriVent BioPharma Inc. have pricing power2025 Buyback Activity & Precise Trade Entry Recommendations - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Can ArriVent BioPharma Inc. hit a new high this month2025 Volume Leaders & High Conviction Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of ArriVent BioPharma Inc. visualizedMarket Movement Recap & Safe Entry Momentum Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Institutional Tools Highlight Unusual Flow in ArriVent BioPharma Inc.July 2025 Movers & Weekly Breakout Stock Alerts - beatles.ru

Sep 03, 2025
pulisher
Sep 03, 2025

Earnings visualization tools for ArriVent BioPharma Inc.Fed Meeting & Technical Confirmation Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is this a good reentry point in ArriVent BioPharma Inc.Quarterly Portfolio Review & High Conviction Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Nuveen LLC Takes $819,000 Position in ArriVent BioPharma, Inc. $AVBP - Defense World

Sep 03, 2025
pulisher
Sep 03, 2025

Regression analysis insights on ArriVent BioPharma Inc. performanceMarket Rally & High Conviction Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How high can ArriVent BioPharma Inc. stock goDip Buying & Free Fast Entry Momentum Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will ArriVent BioPharma Inc. outperform the marketJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will breakout in ArriVent BioPharma Inc. lead to full recoveryEntry Point & Stock Market Timing Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Understanding ArriVent BioPharma Inc.’s price movement2025 Price Momentum & Scalable Portfolio Growth Methods - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

What to expect from ArriVent BioPharma Inc. in the next 30 daysJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is now a turning point for SmartKem Inc.July 2025 Market Mood & Breakout Confirmation Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 03:06:28 - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Watch for Bullish Crossover in ArriVent BioPharma Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스

Sep 01, 2025
pulisher
Sep 01, 2025

Analyzing recovery setups for ArriVent BioPharma Inc. investors2025 Dividend Review & Community Consensus Trade Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What recovery options are there for ArriVent BioPharma Inc.July 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Full technical analysis of ArriVent BioPharma Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Automated trading signals detected on ArriVent BioPharma Inc.Portfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Risk adjusted return profile for ArriVent BioPharma Inc. analyzedPortfolio Update Summary & Proven Capital Preservation Methods - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Volatility clustering patterns for ArriVent BioPharma Inc.2025 Short Interest & Safe Swing Trade Setup Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will ArriVent BioPharma Inc. stock go up soonMarket Growth Review & Low Risk High Reward Ideas - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

ArriVent BioPharma Inc. stock prediction for this weekStop Loss & Free Weekly Watchlist of Top Performers - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

What machine learning models say about ArriVent BioPharma Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser

Aug 30, 2025

Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Arrivent Biopharma Inc-Aktie (AVBP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
LaChapelle Robin
Chief Operating Officer
Sep 19 '24
Option Exercise
3.28
27,566
90,481
124,583
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):